Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI)
PHASE2
To establish optimal dosing of lyophilized Fecal microbiota transplantation...
Status
Terminated
Location
The University of Texas Health Science Center at Houston
Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis
PHASE2
The purpose of the study is to evaluate the efficacy and safety of lyophili...
Status
Recruiting
Location
The University of Texas Health Science Center at Houston